(SLE)
ANETUMAB KORIXETAN(INNC)
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-[HOMO SAPIENS MSLN (MESOTHELIN, PRE-PRO-MEGAKARYOCYTE-POTENTIATING FACTOR, MEGAKARYOCYTE-POTENTIATING FACTOR, MPF, CAK1)], HOMO SAPIENS MONOCLONAL ANTIBODY,CONJUGATED TO CHELATOR CORIXETAN; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-450) [VH (HOMO SAPIENS IGHV5-51*01 (94.9%) -(IGHD) -IGHJ4*01 (86.7%)) [8.8.13] (1- 120) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359) L14 (361) (344-448), CHS (449-450)) (121-450)], (223- 216')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-217') [VLAMBDA (HOMO SAPIENS IGLV2-14*01 (95.6%) -IGKJ2*01 (100%)) [9.3.11] (1'-111') -HOMO SAPIENS IGLC2*01 (99.1%) A43>G (155) (112'-217')]; DIMER (229-229'':232-232'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-S CELL LINE, GLYCOFORM ALFA; CONJUGATED TO CHELATOR CORIXETAN, WITH AN AVERAGE OF 0.5 CHELATOR PER ANTIBODY(WHOM)
ANETUMABUM CORIXETANUM(INNM)